Neuroendocrine, Carcinoma

Neuroendocrine Carcinoma Market Poised for Significant Growth During the Forecast Period Driven by Rising Incidence and Advancements in Targeted Therapies | DelveInsight

Veröffentlicht: 17.03.2026 um 17:48 Uhr, prnewswire.co.uk

DelveInsight Business Research, LLP United Kingdom United States of America

en | boerse | 68716813 |